Guru Ownership Trend
Guru Analysis for Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $218.22 M.
Top institutional holders include Catherine Wood and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $31.38 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 156.9%. Conversely, Murray Stahl reduced exposure by 4.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Intellia Therapeutics, Inc. (NTLA)
Major holders include Catherine Wood ($127.72 M), Renaissance Technologies (RenTech) ($15.04 M), Cliff Asness ($2.82 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 16.62 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $31.38 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited NTLA. The total reported sell value was $3.01 M.
Yes, 2 managers opened new positions in NTLA, and 3 increased their existing holdings. The total reported buy value was $34.39 M.
